BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17513921)

  • 41. Guidelines for screening and treatment of cervical disease in the adolescent.
    Guido R
    J Pediatr Adolesc Gynecol; 2004 Oct; 17(5):303-11. PubMed ID: 15581775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.
    Holmes J; Hemmett L; Garfield S
    Eur J Health Econ; 2005 Mar; 6(1):30-7. PubMed ID: 15682286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses.
    Chouhy D; Gil LB; Nocito AL; Wojdyla D; Ornella L; Cittadini J; Gardiol D; Giri AA
    Int J Mol Med; 2006 Nov; 18(5):995-1003. PubMed ID: 17016633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
    Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
    Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dutch solutions for liquid-based cytology: analysis of unsatisfactory slides and HPV testing of equivocal cytology.
    Boon ME; Rijkaart DC; Ouwerkerk-Noordam E; Korporaal H
    Diagn Cytopathol; 2006 Sep; 34(9):644-8. PubMed ID: 16900471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is a Pap smear enough?
    Heley S
    Aust Fam Physician; 2001 Jun; 30(6):535-8. PubMed ID: 11458579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular testing of human papillomavirus in cervical specimens.
    Gazzaz FB
    Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for cervical cancer: is there a place for incorporating tests for the human papillomavirus?
    Beral V; Day NE
    IARC Sci Publ; 1992; (119):263-9. PubMed ID: 1330916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPV: from the cervical smear to the research bench to the court room.
    Atkins K
    Clin Leadersh Manag Rev; 2003; 17(6):341-5. PubMed ID: 14692078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus: emerging trends in detection and management.
    Wright JD; Herzog TJ
    Curr Womens Health Rep; 2002 Aug; 2(4):259-65. PubMed ID: 12150752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
    Nishino HT; Tambouret RH; Wilbur DC
    Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV testing and cervical cancer screening: recommendations and practice patterns.
    Madom LM; Boardman LA
    Med Health R I; 2005 Oct; 88(10):362-3. PubMed ID: 16353376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term cervical cancer prevention strategies across the globe.
    Cuzick J
    Gynecol Oncol; 2010 May; 117(2 Suppl):S11-4. PubMed ID: 20129652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Translational approaches to improving cervical screening.
    Baldwin P; Laskey R; Coleman N
    Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cervical cancer screening: current status and perspectives].
    Petignat P; Bouchardy C; Sauthier P
    Rev Med Suisse; 2006 May; 2(66):1308-9, 1311-2. PubMed ID: 16775991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of non-invasive sampling methods for detection of HPV in rural African women.
    Lack N; West B; Jeffries D; Ekpo G; Morison L; Soutter WP; Walraven G; Boryseiwicz L
    Sex Transm Infect; 2005 Jun; 81(3):239-41. PubMed ID: 15923294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New technologies in gynecologic cytology.
    Bishop JW; Marshall CJ; Bentz JS
    J Reprod Med; 2000 Sep; 45(9):701-19. PubMed ID: 11027079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.